TRUPFinancial Services · Insurance - Property & CasualtyThe 6 Wall Street analysts covering Trupanion, Inc. hold a median 12-month price target of $33 — +32.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 35 of 100 as at 12 Sept 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Trupanion, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (84): Analysts have, on balance, been raising their forecasts.
Momentum (10): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on TRUP, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +32.6% from it.
Of the 20 most recent actions, 1 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 Aug 2026 | Piper Sandler | Downgrade | Neutral | $45 → $32 |
| 20 Aug 2026 | Stifel | Maintains | Hold | $28 → $29 |
| 14 Apr 2026 | B of A Securities | Maintains | Buy | $63 → $59 |
| 14 Apr 2026 | B of A Securities | Maintains | Buy | — |
| 9 Apr 2026 | Cantor Fitzgerald | Maintains | Neutral | — |
| 9 Apr 2026 | Cantor Fitzgerald | Maintains | Neutral | $42 → $34 |
| 31 Mar 2026 | Stifel | Maintains | Hold | — |
| 13 Feb 2026 | Piper Sandler | Maintains | Overweight | — |
| 13 Feb 2026 | Stifel | Maintains | Hold | — |
| 29 Jan 2026 | Stifel | Maintains | Hold | — |
| 14 Jan 2026 | Cantor Fitzgerald | Maintains | Neutral | — |
| 19 Dec 2025 | Piper Sandler | Maintains | Overweight | — |
| 18 Nov 2025 | Stifel | Maintains | Hold | — |
| 8 Aug 2025 | Piper Sandler | Maintains | Overweight | — |
| 8 Aug 2025 | Stifel | Maintains | Hold | — |
| 3 July 2025 | Piper Sandler | Maintains | Overweight | — |
| 2 May 2025 | Lake Street | Maintains | Buy | — |
| 20 Feb 2025 | Piper Sandler | Maintains | Overweight | — |
| 20 Feb 2025 | Stifel | Maintains | Hold | — |
| 23 Jan 2025 | Piper Sandler | Upgrade | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. TRUP appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 11 Sept 2026, Trupanion, Inc. returned −42.7% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 15% of US stocks
Cheaper than 76% of US stocks
Cheaper than 36% of US stocks
Cheaper than 16% of US stocks
Higher than 55% of US stocks
Higher than 17% of US stocks
Higher than 16% of US stocks
Higher than 48% of US stocks
Higher than 51% of US stocks
Higher than 55% of US stocks
Higher than 57% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Trupanion, Inc. has a market value of $1.1B and an enterprise value of $800.4M.
Revenue in the twelve months to 30 June 2026: $1.5B. The latest quarter grew 11.1% year on year.
Net income over the same four quarters: $23.2M, a 1.5% net margin.
Diluted earnings per share, trailing twelve months: $0.53.
Free cash flow in the twelve months to 30 June 2026: $82.2M.
Trupanion, Inc. spent $3.0M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 47.0×; forward P/E: 5.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Trupanion, Inc. employs 1,121 people — $1.4M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Trupanion, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Trupanion announced the return of its annual truFame contest, which searches for this year's "It Pets" as the company's next four-legged stars. The announcement was made from Seattle on September 10, 2026.
Why it matters — The truFame contest is a customer-engagement and brand-awareness initiative that could help Trupanion build community and promote its pet insurance brand.
Trupanion's estimated economic combined ratio improved to 98.5% in H1 2026, extending the underwriting profitability first achieved in 2025, aided by operating leverage and lower acquisition costs. The H1 loss ratio declined to 71.0% from 72.1%, and management's 2026 guidance could imply $32–$40 million of net income, suggesting scale is translating into profitability.
Why it matters — The report signals that Trupanion's path to sustainable underwriting profitability is firming up, while still flagging its valuation as expensive.
Trupanion announced a partnership with Home To Home® aimed at helping more pets transition directly from one loving home to another. The announcement was made on Aug. 13, 2026, in Seattle via GlobeNewsWire.
Why it matters — A TRUP watcher would care because this collaboration broadens Trupanion's community and pet-wellness initiatives, potentially supporting pet retention and strengthening its brand relationships.
Zacks Investment Research highlighted that accident and health insurers including Trupanion (TRUP) are positioned to benefit from rising underwriting exposure and accelerated digitalization, though pricing pressure from elevated medical costs and inflation remains a concern.
Why it matters — The report directly addresses TRUP as one of four insurers facing both tailwinds from underwriting growth and headwinds from rising healthcare costs, which are key factors for investors monitoring the company's profitability.
Trupanion's second-quarter earnings exceeded estimates with an 11% increase in revenue, though the article notes the stock's premium valuation and subdued analyst sentiment.
Why it matters — The mixed picture of a solid earnings beat alongside valuation concerns and muted analyst sentiment suggests a cautious outlook for TRUP investors.
The 6 Wall Street analysts covering Trupanion, Inc. have a median 12-month price target of $33, with estimates ranging from $29 to $42. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Trupanion, Inc., 2 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Trupanion, Inc. 35 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 12 Sept 2026, Trupanion, Inc. ranks 35 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (84 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies +32.6% from the last close, and Ticker Nerd's factor model ranks Trupanion, Inc. 35 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Trupanion, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TRUP are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $29 to $42 over the next 12 months.
Trupanion, Inc. returned -42.7% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Trupanion Inc. is a pet insurance provider that specializes in medical insurance for cats and dogs.
The most recent item we track (GlobeNewsWire, 10 Sept 2026): "Trupanion Searches for this Year's “It Pets” With Return of Annual truFame Contest". Trupanion announced the return of its annual truFame contest, which searches for this year's "It Pets" as the company's next four-legged stars. The announcement was made from Seattle on September 10, 2026.
Trupanion Inc. is a pet insurance provider that specializes in medical insurance for cats and dogs. The company offers subscription-based coverage designed to help pet owners manage veterinary costs through products focused on illness and injury care. Its business also includes tools and services that support direct payment to veterinarians, streamlining the claims and checkout process for pet medical expenses. Trupanion serves pet owners and veterinary partners across the United States and Canada, with additional operations in select international markets. The company operates through subscription and other business channels, combining consumer insurance offerings with partner-based distribution and related software solutions. Trupanion Inc. plays a specialized role in the animal health and insurance markets by providing coverage products tailored to companion animals and the veterinary care ecosystem.
CEO Ms. Margaret Rosemary Maria Tooth · 1,121 employees · United States · https://www.trupanion.com
